A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Clinical trial NCT04007107 · COMPLETED

Trial details

NCT number: NCT04007107
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers Diabetes Mellitus, Type 2 Healthy Volunteers Overweight Healthy Volunteers Obesity

Start date: 2019-06-27
Primary completion: 2019-07-28
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.